228 related articles for article (PubMed ID: 17664527)
1. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia.
Goodenowe DB; Cook LL; Liu J; Lu Y; Jayasinghe DA; Ahiahonu PW; Heath D; Yamazaki Y; Flax J; Krenitsky KF; Sparks DL; Lerner A; Friedland RP; Kudo T; Kamino K; Morihara T; Takeda M; Wood PL
J Lipid Res; 2007 Nov; 48(11):2485-98. PubMed ID: 17664527
[TBL] [Abstract][Full Text] [Related]
2. Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers.
Maeba R; Araki A; Fujiwara Y
Adv Clin Chem; 2018; 87():69-111. PubMed ID: 30342713
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids.
Yamashita S; Kiko T; Fujiwara H; Hashimoto M; Nakagawa K; Kinoshita M; Furukawa K; Arai H; Miyazawa T
J Alzheimers Dis; 2016; 50(2):527-37. PubMed ID: 26682681
[TBL] [Abstract][Full Text] [Related]
4. Oral Administration of Ethanolamine Glycerophospholipid Containing a High Level of Plasmalogen Improves Memory Impairment in Amyloid β-Infused Rats.
Yamashita S; Hashimoto M; Haque AM; Nakagawa K; Kinoshita M; Shido O; Miyazawa T
Lipids; 2017 Jul; 52(7):575-585. PubMed ID: 28551706
[TBL] [Abstract][Full Text] [Related]
5. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
Wood PL; Smith T; Lane N; Khan MA; Ehrmantraut G; Goodenowe DB
Lipids Health Dis; 2011 Dec; 10():227. PubMed ID: 22142382
[TBL] [Abstract][Full Text] [Related]
6. Dietary plasmalogen increases erythrocyte membrane plasmalogen in rats.
Mawatari S; Katafuchi T; Miake K; Fujino T
Lipids Health Dis; 2012 Nov; 11():161. PubMed ID: 23170810
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor.
Wood PL; Khan MA; Smith T; Ehrmantraut G; Jin W; Cui W; Braverman NE; Goodenowe DB
Lipids Health Dis; 2011 Oct; 10():182. PubMed ID: 22008564
[TBL] [Abstract][Full Text] [Related]
8. Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition.
Liu Y; Cong P; Zhang T; Wang R; Wang X; Liu J; Wang X; Xu J; Wang Y; Wang J; Xue C
Redox Biol; 2021 Jul; 43():102002. PubMed ID: 33984602
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of plasmalogen by phospholipase A1 from Streptomyces albidoflavus for early detection of dementia and arteriosclerosis.
Sakasegawa SI; Maeba R; Murayama K; Matsumoto H; Sugimori D
Biotechnol Lett; 2016 Jan; 38(1):109-16. PubMed ID: 26354853
[TBL] [Abstract][Full Text] [Related]
10. Marine Plasmalogens: A Gift from the Sea with Benefits for Age-Associated Diseases.
Yamashita S; Miyazawa T; Higuchi O; Kinoshita M; Miyazawa T
Molecules; 2023 Aug; 28(17):. PubMed ID: 37687157
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Plasmalogen Species in Foodstuffs.
Yamashita S; Kanno S; Honjo A; Otoki Y; Nakagawa K; Kinoshita M; Miyazawa T
Lipids; 2016 Feb; 51(2):199-210. PubMed ID: 26732602
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport.
Munn NJ; Arnio E; Liu D; Zoeller RA; Liscum L
J Lipid Res; 2003 Jan; 44(1):182-92. PubMed ID: 12518037
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic absorption of choline plasmalogen is much higher than that of ethanolamine plasmalogen in rats.
Nishimukai M; Yamashita M; Watanabe Y; Yamazaki Y; Nezu T; Maeba R; Hara H
Eur J Nutr; 2011 Sep; 50(6):427-36. PubMed ID: 21152926
[TBL] [Abstract][Full Text] [Related]
14. Plasmalogen precursor analog treatment reduces levodopa-induced dyskinesias in parkinsonian monkeys.
Grégoire L; Smith T; Senanayake V; Mochizuki A; Miville-Godbout E; Goodenowe D; Di Paolo T
Behav Brain Res; 2015 Jun; 286():328-37. PubMed ID: 25771209
[TBL] [Abstract][Full Text] [Related]
15. Serum ethanolamine plasmalogens improve detection of cognitive impairment among elderly with high excretion levels of urinary myo-inositol: A cross-sectional study.
Maeba R; Araki A; Ishii K; Ogawa K; Tamura Y; Yasunaga M; Minami U; Komori A; Okazaki T; Nishimukai M; Hara H; Fujiwara Y
Clin Chim Acta; 2016 Jan; 453():134-40. PubMed ID: 26680299
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
17. Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects.
Wood PL; Barnette BL; Kaye JA; Quinn JF; Woltjer RL
Acta Neuropsychiatr; 2015 Oct; 27(5):270-8. PubMed ID: 25858158
[TBL] [Abstract][Full Text] [Related]
18. Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study.
Mankidy R; Ahiahonu PW; Ma H; Jayasinghe D; Ritchie SA; Khan MA; Su-Myat KK; Wood PL; Goodenowe DB
Lipids Health Dis; 2010 Jun; 9():62. PubMed ID: 20546600
[TBL] [Abstract][Full Text] [Related]
19. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.
Han X; Holtzman DM; McKeel DW
J Neurochem; 2001 May; 77(4):1168-80. PubMed ID: 11359882
[TBL] [Abstract][Full Text] [Related]
20. Absorption Kinetics of Ethanolamine Plasmalogen and Its Hydrolysate in Mice.
Yamashita S; Fujiwara K; Tominaga Y; Nguma E; Takahashi T; Otoki Y; Yamamoto A; Higuchi O; Nakagawa K; Kinoshita M; Miyazawa T
J Oleo Sci; 2021 Feb; 70(2):263-273. PubMed ID: 33456005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
